Gestational hypertension/preeclampsia/eclampsia/HELLP: clinical

文摘   科学   2024-07-29 07:00   澳大利亚  
If you would like to view past exciting content, please click on the following link.
Biliary colic-clinical approach
Periumbilical and lower abdominal pain-clinical approach
Upper abdominal pain-clinical approach
Postoperative abdominal pain-clinical approach
Pneumoperitoneum and peritonitis-clinical approach
Abdominal aortic aneurysm-clinical approach
Acute mesenteric ischemia-clinical approach
Acute pancreatitis-clinical approach
Adnexal torsion-clinical approach
Aortic dissection-clinical approach
Appendicitis-clinical approach
Alcohol-induced hepatitis-clinical approach
Chronic mesenteric ischemia-clinical approach
Cholecystitis-clinical approach
Choledocholithiasis and cholangitis-clinical approach
Chronic pancreatitis-clinical approach
Diverticulitis-clinical approach
Colonic volvulus-clinical approach
Colorectal cancer-clinical approach
Gastric cancer-clinical approach
Gastroesophageal reflux disease-clinical approach
Infectious gastroenteritis-clinical approach
Irritable bowel syndrome-clinical approach
Ischemic colitis-clinical approach
Large bowel obstruction-clinical approach
Peptic ulcer disease-clinical approach
Small bowel obstruction-clinical approach
Spontaneous bacterial peritonitis-clinical approach
Inflammatory bowel disease(ulcerative colitis)-clinical approach
Inflammatory bowel disease (Crohn disease)-clinical approach
Major depressive disorder-clinical approach
Bipolar disorder-clinical approach
Fatigue-clinical approach
Hypothyroidism-clinical approach
Trauma- and stress-related disorders-clinical approach
Epstein-Barr virus (Infectious mononucleosis)-clinical approach
Multiple sclerosis-clinical approach
Anorexia nervosa-clinical approach
Bulimia nervosa-clinical approach
Eating disorders-clinical approach
Body dysmorphic disorder
Mood disorders
Schizoaffective disorder
Schizophrenia
Schizophrenia spectrum disorders
Gastroesophageal reflux disease: clinical approach
Schizophrenia spectrum disorders-V2
Hyperthyroidism
Hyperthyroidism-with cases
Hyperthyroidism and thyrotoxicosis-clinical approach
Hyperthyroidism-V2
Central nervous system infections-with cases
Traumatic brain injury-clinical approach
Post-traumatic stress disorder
Peri/menopause/primary ovarian insufficiency: clinical approach
Sleep apnea-clinical approach
Generalized anxiety disorder
Anxiety disorders/phobias/stress-related disorders with cases
Panic disorder
Phobias
Obsessive compulsive disorders
Tobacco use disorder
Epilepsy
Hypoglycemia: clinical approach
Malingering, factitious disorders and somatoform disorders
Stroke
Tachycardia: clinical approach
Wolff-Parkinson-White syndrome
Hypovolemic shock: clinical approach
Opioid intoxication and overdose: clinical approach
Drug misuse/intoxication/withdrawal: some depressants with cases
Delirium: clinical approach
Substance misuse and addiction
Adult brain tumors
Pediatric brain tumors
Chest pain: clinical approach
Infectious endocarditis: clinical approach
Pulmonary embolism: clinical approach
Chronic bronchitis
Community-acquired pneumonia: clinical approach
Hospital-acquired/ventilator-associated pneumonia: clinical appr
Acute coronary syndrome: clinical approach
Coronary artery disease (un/stable angina): clinical approach
Typical antipsychotics
Atypical antipsychotics
Essential tremor
Alcohol withdrawal: clinical approach
Cirrhosis: clinical approach
Hepatic encephalopathy
Beriberi
Orthostatic hypotension
Valvular heart diseases
Somatic symptom disorders
Headache with cases
Polycystic ovary syndrome (PCOS): clinical approach
Hydration
Pregnancy
Parkinson's disease
Dementia with cases
Diabetes mellitus (Type 1): clinical approach
Diabetes mellitus (Type 2): clinical approach
Preconception care: clinical approach
Systemic lupus erythematosus: clinical approach
Antepartum care (first trimester): clinical approach
Antepartum care (second trimester): clinical approach
Antepartum care (third trimester): clinical approach
Ectopic pregnancy: clinical approach
Acute pelvic pain: clinical approach
First trimester bleeding: clinical approach
Pelvic inflammatory disease: clinical approach
Ovarian cyst
Nephrolithiasis: clinical approach
Pyelonephritis: clinical approach
Lower urinary tract infection: clinical approach
Congenital infections: clinical approach
Hypertension in pregnancy encompasses a range of disorders, beginning with gestational hypertension, which is characterized solely by elevated blood pressure. When proteinuria is added to hypertension, it indicates preeclampsia without severe features. The progression to preeclampsia with severe features is marked by the presence of severely elevated blood pressures, laboratory evidence of end-organ damage such as thrombocytopenia, elevated liver enzymes, or renal insufficiency, and concerning symptoms like new-onset headache, visual changes, right upper quadrant pain, or epigastric pain.
HELLP syndrome is identified when a patient exhibits Hemolysis, Elevated Liver enzymes, and Low Platelets. These conditions pose significant risks to both the mother and fetus, including stroke, pulmonary edema, renal failure, and placental abruption. If a seizure occurs, it is classified as eclampsia. Most hypertensive disorders resolve within 12 weeks postpartum, but they increase the patient's risk of developing chronic hypertension in the future.
The first step in evaluating a pregnant patient presenting with symptoms suggestive of a hypertensive disorder is to perform a CABCDE assessment and conduct a primary obstetric survey.
For unstable patients, check for uncontrolled bleeding and manage any hemorrhage, as severely elevated blood pressure may lead to placental abruption. Stabilize the airway, breathing, and circulation, and consider intubation if necessary. Establish IV access and continuously monitor maternal vital signs. Conduct the primary obstetric survey, which includes monitoring the fetal heart rate, potentially testing for rupture of amniotic membranes, and assessing cervical dilation.
For stable patients, begin with a focused history and physical exam. Inquire about any history of hypertension, a significant risk factor, and other risk factors such as obesity, diabetes, kidney disease, age over 35, nulliparity, multifetal gestation, or a history of preeclampsia.
Measure the patient's blood pressure. Hypertensive disorders of pregnancy are suspected in patients more than 20 weeks pregnant if they have newly elevated blood pressures of at least 140 systolic or 90 diastolic, or both, on two separate occasions more than 4 hours apart.
Once a hypertensive disorder is suspected, check labs including CBC, CMP, LDH, and a urine protein-to-creatinine ratio, and possibly conduct a 24-hour urine collection to measure total protein.
If the patient has normal labs and no symptoms of preeclampsia, gestational hypertension can be diagnosed. Antepartum management involves monitoring blood pressure and initiating antihypertensive medication like labetalol or nifedipine if blood pressure remains above 140 systolic or 90 diastolic. Antenatal fetal surveillance with non-stress tests and serial ultrasounds to assess fetal growth is recommended.
Monitor for disease progression by regularly assessing blood pressure, performing serial labs, and asking about symptoms of preeclampsia with severe features. If maternal and fetal status are stable, delivery can be planned for 37 weeks, with vaginal delivery being appropriate unless contraindicated by factors such as fetal malpresentation or a prior classical C-section.
During labor, closely monitor maternal and fetal status for severe features, as these require additional interventions. Postpartum, schedule a short-interval blood pressure check and discuss return precautions for signs and symptoms of preeclampsia with severe features. Half of all patients with gestational hypertension will eventually develop preeclampsia, with the highest risk in those diagnosed before 32 weeks, underscoring the importance of close monitoring for disease progression.
Now let’s discuss patients with proteinuria. Patients who develop new-onset hypertension after 20 weeks of gestation along with proteinuria meet the criteria for a diagnosis of preeclampsia. Proteinuria is defined as a urine protein-to-creatinine ratio of 0.3 or higher, or a 24-hour urine collection with at least 300 mg of protein.
Upon diagnosing preeclampsia, the next step is to assess for severe features. These include blood pressures of at least 160 systolic or 110 diastolic on two occasions at least 4 hours apart; laboratory abnormalities such as thrombocytopenia with a platelet count below 100,000, renal insufficiency with a creatinine level above 1.1, elevated liver function tests more than twice the upper limit of normal; and signs or symptoms like pulmonary edema, a new-onset headache that does not improve with medication, visual disturbances like spots or blurry vision, severe, persistent right upper quadrant abdominal pain, or epigastric pain.
Here’s a clinical pearl! While blood pressure should be measured on two separate occasions at least 4 hours apart, in an acute setting with severely elevated blood pressures, the diagnosis can be made within minutes to allow for timely intervention.
Patients with preeclampsia without severe features should be monitored closely in an outpatient setting. Consider initiating an antihypertensive if blood pressure remains above 140 systolic, 90 diastolic, or both. Begin antenatal fetal surveillance with non-stress tests and serial ultrasounds, and monitor for severe features with serial labs and symptomatology. If they remain asymptomatic for severe features with reassuring blood pressure, fetal status, and labs, vaginal delivery at 37 weeks is recommended.
During labor, start an antihypertensive if elevated blood pressures occur, and closely monitor both maternal and fetal status. After delivery, schedule a short-interval blood pressure check and review return precautions for signs and symptoms of preeclampsia with severe features.
For patients exhibiting at least one severe feature, the diagnosis is preeclampsia with severe features. These patients should be admitted to the hospital for the remainder of their pregnancy for close maternal and fetal monitoring. Control severe-range blood pressures with antihypertensives like labetalol, nifedipine, or hydralazine, and consider starting a maintenance antihypertensive. Administer magnesium sulfate to prevent seizures. If the patient is preterm, consider giving corticosteroids to promote fetal lung maturity. If maternal and fetal status are reassuring, delivery should occur at 34 weeks, or at the time of diagnosis if further along.
If patients become unstable, indicated by uncontrolled blood pressures despite antihypertensives, abnormal or worsening labs, or unresolved symptoms of headache, visual changes, right upper quadrant, or epigastric pain, immediate delivery is necessary. Vaginal delivery is appropriate unless contraindicated.
During labor, control severe-range blood pressures, consider starting or adjusting maintenance antihypertensives, and administer magnesium sulfate. Monitor fluid status to prevent volume overload and pulmonary edema, and closely observe maternal and fetal status. Post-delivery, continue antihypertensive medications as indicated and magnesium sulfate for 24 hours. Before discharge, schedule a short-interval blood pressure check and review return precautions for preeclampsia with severe features.
Finally, let’s review HELLP syndrome, a severe form of preeclampsia. HELLP syndrome is characterized by its hallmark lab findings: Hemolysis, indicated by elevated LDH above 600; Elevated Liver function tests more than twice the upper limit of normal; and Low Platelets below 100. Patients may also present with proteinuria, right upper quadrant pain, generalized malaise, and severe-range blood pressure.
HELLP syndrome can progress rapidly, so swift action is crucial! Start treatment with magnesium sulfate, control severe-range blood pressures, and deliver the fetus; vaginal delivery is appropriate unless contraindicated. During labor, consider maintenance antihypertensive medication, manage severe-range blood pressures, continue magnesium sulfate, and closely monitor maternal and fetal status. Patients with HELLP syndrome are at increased risk for disseminated intravascular coagulation (DIC), so closely watch for bleeding from wounds or IV sites and signs of coagulopathy.
Postpartum, continue antihypertensives as indicated and magnesium sulfate for 24 hours. Additionally, monitor lab values for a return to baseline. Schedule a follow-up shortly after discharge for a blood pressure check, and provide return precautions for preeclampsia with severe features.
Let’s conclude with eclampsia. Eclampsia is diagnosed by a new-onset seizure in pregnancy not explained by other causes like epilepsy, stroke, or drug use. Patients may have warning signs of cerebral irritation before seizing, such as severe occipital or frontal headaches, visual symptoms like blurry vision or photophobia, and possible altered mental status. While most patients who develop eclampsia will exhibit classic signs of preeclampsia, such as hypertension or proteinuria, a small proportion will not.
Eclampsia requires immediate management. Call for help and activate an emergency response team. Provide maternal cardiorespiratory support by placing the patient on their left side, suctioning their airway to prevent aspiration, administering oxygen, and monitoring vital signs. Most eclamptic seizures resolve without medication, but if seizures persist, administer medications like benzodiazepines. Once the seizure has stopped, start magnesium sulfate to prevent recurrence and control severe-range blood pressures with antihypertensives. Once stabilized, deliver the fetus; vaginal delivery is appropriate unless contraindicated.
During labor, continue antihypertensives, magnesium sulfate, close maternal and fetal monitoring, and fluid management. Post-delivery, continue antihypertensive medications as needed and magnesium sulfate for 24 hours. Schedule a short-interval blood pressure check after discharge and provide return precautions for signs or symptoms of worsening disease.
Here’s a clinical pearl! Remember that preeclampsia with and without severe features, eclampsia, and HELLP syndrome can all present for the first time even after delivery, during the postpartum period.
Here’s a quick recap:
- **Patients with gestational hypertension or preeclampsia without severe features**: Managed with antenatal fetal surveillance, monitoring for disease progression, and delivery at 37 weeks, or at the time of diagnosis if further along than 37 weeks.
- **Preeclampsia with severe features**: Requires immediate intervention to control elevated blood pressures, seizure prophylaxis with magnesium sulfate, and delivery by 34 weeks, or at the time of diagnosis if further along.
- **HELLP syndrome and eclampsia**: These are severe forms of preeclampsia and require magnesium sulfate and immediate delivery.
Ref:
"ACOG committee opinion no. 828: Indications for outpatient antenatal fetal surveillance" Obstet Gynecol (2021)
"ACOG practice bulletin no. 222: Gestational hypertension and preeclampsia" Obstet Gynecol (2020)

 - - - - - - -  END - - - - - - - 


作者:Joy,

澳洲最佳高校非首席脑科学科学家/博导,

德国精英大学非精英医学博士,

欢迎合作让我们一起成为首席和精英:

MRYIXUEYANJIU666

请加上述微信进博士职位申请交流群,

欢迎前往公众号菜单栏查阅更多内容,

常用科研技能集锦,

零基础入门R语言,

医学生申请出国读博教程,

GraphPad Prism使用教程,

Image J使用教程,

好书推(请加上述微信进购书/购物优惠群

医学研究笔记
医学研究笔记,助力医学科研。
 最新文章